Form 4 holding
10%+ Owner
GYRE THERAPEUTICS, INC.
- Security class
- Common Stock
- Shares / value
- 64,005,887
- Estimated value
- $30,082,767
- Report date
- 30 Oct 2023
- Price
- $0.4700
- Ownership
- See Remarks
GNI Group Ltd. - 10%+ Owner at GYRE THERAPEUTICS, INC.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- GYRE on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by GNI Group Ltd. since 09 Sep 2025
Reported holdings for GNI Group Ltd. in GYRE THERAPEUTICS, INC.
Form 4 holding
10%+ Owner
GYRE THERAPEUTICS, INC.
- Security class
- Series X Convertible Preferred Stock Warrant (Right to Buy)
- Shares / value
- 8,110,300
- Estimated value
- $1,013,788
- Report date
- 27 Oct 2023
- Price
- $0.1250
- Ownership
- Indirect
- Underlying class
- Series X Convertible Preferred Stock
- Underlying amount
Form 4 holding
10%+ Owner
GYRE THERAPEUTICS, INC.
- Security class
- Series B Preferred Stock
- Shares / value
- 2,143,706
- Estimated value
- Report date
- 04 May 2026
- Price
- Ownership
- See Remarks
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
GYRE THERAPEUTICS, INC.
- Security class
- Series B Preferred Stock
- Shares / value
- 2,143,706
- Estimated value
- Report date
- 04 May 2026
- Price
- Ownership
- See Remarks
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
GYRE THERAPEUTICS, INC.
- Security class
- Series X Convertible Preferred Stock
- Shares / value
- 13,151
- Estimated value
- Report date
- 27 Oct 2023
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
CATALYST BIOSCIENCES, INC.
- Security class
- Series Y Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 31 Aug 2023
- Price
- Ownership
- Direct
Transaction history for GNI Group Ltd. in GYRE THERAPEUTICS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.